DOCSLIB.ORG

Information for Authors and Journal Policies

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Information for Authors and Journal Policies Information for Authors and Journal Policies ARTICLE TYPES ................................................ 2 Prepublication Embargo ................................... 11 Original Investigations ........................................ 2 Copyright........................................................... 11 Case Series .................................................... 2 Article Access ................................................... 12 Clinical Trial .................................................... 2 Open Access User Licenses ......................... 12 Decision Analysis or Cost-Effectiveness Open Access Publication Fee ....................... 12 Analysis ................................................ 2 Compliance With NIH Public Access Policy . 12 Diagnostic Test Study..................................... 2 Article Preproofs ............................................... 12 Observational Study ....................................... 2 Article Proofs .................................................... 12 Quality Improvement Study ............................ 3 Page Charges ................................................... 12 Systematic Review or Meta-analysis.............. 3 Color Reproduction Charges ............................ 12 Research Letters ................................................ 3 Share Link and Reprints ................................... 13 Case Reports ..................................................... 4 Retained Author Rights .................................... 13 Features ............................................................. 4 CrossMark and Digital Preservation ................. 13 Editorial ........................................................... 4 OTHER EDITORIAL POLICIES ........................ 13 In a Few Words .............................................. 4 Ethics in Publishing........................................... 13 Review ............................................................ 4 Review Policy ................................................... 13 Perspective ..................................................... 4 Author Appeal Policy ........................................ 13 Quiz………………………………………………4 Special Report ................................................ 5 Conflict of Interest Policy .................................. 13 OTHER CONTENT ............................................. 5 Potential Author COIs ................................... 13 Letters to the Editor ............................................ 5 Potential Reviewer COIs ............................... 14 Potential Editor COIs .................................... 14 Custom Features ................................................ 5 Correction Policy ............................................... 14 SUBMISSION POLICIES .................................... 5 Misconduct Handling Policy .............................. 14 Originality ........................................................... 5 Complaint Policy ............................................... 14 Related Submissions ...................................... 5 Advertising Policy ............................................. 14 Presubmission Dissemination ........................ 5 Reuse of Copyrighted Material ....................... 6 Supplement Policy ............................................ 15 Authorship .......................................................... 6 Potential Conflicts of Interest for Authors........... 6 EDITORIAL OFFICE CONTACT INFORMATION Support ........................................................... 6 Office E-mail: [email protected] Financial Disclosure ....................................... 7 Direct Line to Managing Editor Nijsje Dorman: Other Disclosures ........................................... 7 +1 215-746-4467 Patient/Participant Protections ........................... 7 The AJKD Editorial Office is based at the Center for Clinical Trial Registration ................................... 8 Clinical Epidemiology and Biostatistics, Perelman Data Sharing ...................................................... 8 School of Medicine at the University of Pennsylvania, Research and Publication Integrity .................... 8 Philadelphia, Pennsylvania MANUSCRIPT PREPARATION GUIDANCE ..... 9 American Journal of Kidney Diseases Title Page ........................................................... 9 Print ISSN: 0272-6386 Manuscript Body................................................. 9 Electronic ISSN: 1523-6838 Abstract .............................................................. 9 Key updates to this document in 2020: Units of Measurement ...................................... 10 • Policy on prior dissemination updated (preprints Reporting P Values .......................................... 10 identified as an exception) Reference Style ................................................ 10 • Patient protection policies for Case Reports Tables and Figures........................................... 10 clarified • Document reorganized to better distinguish MANUSCRIPT CONSIDERATION PROCESS 10 mandatory policies from style preferences not Standard Consideration Process ..................... 10 obligatory for initial submission AJKD Express (Expedited Consideration) ....... 11 • Information added about preproof publication AFTER ACCEPTANCE ..................................... 11 Page 1 of 15 | Updated November 2020 Information for Authors and Journal Policies The American Journal of Kidney Diseases, requires that the study protocol (with any published monthly by Elsevier on behalf of the amendments identified with date) be included in the National Kidney Foundation (NKF), serves clinicians initial submission as part of the confidential review and scientists who treat and investigate kidney process (publication of the protocol as disease and associated conditions. AJKD is supplementary material or its availability for data dedicated to providing high-quality, clinically relevant sharing would be at the authors’ discretion). information in the form of original research articles, For randomized controlled trials, authors should case reports, and a rich variety of educational include a CONSORT flowchart and follow the CON- features. SORT guidelines matching the study design, eg: ARTICLE TYPES • Trial With Parallel Group Design (more info) Original Investigations • Cluster-Randomized Trial Original Investigations may evaluate pathogenesis, • Noninferiority and Equivalence Trial consequences, and treatment of kidney disease; • Pragmatic Trial kidney transplantation and dialysis therapies; and • Trial of Nonpharmacologic Treatment disorders of blood pressure and electrolyte and acid- • Trial With Patient-Reported Outcomes base balance. Manuscripts must focus on clinical • N-of-1 Trial (more info) research; laboratory studies are suitable only if they Authors should consider following the TIDieR are directly linked to measurements or outcomes in guidance to describe the intervention. If appropriate, humans. Criteria for review include validity, clinical authors should follow CONSORT’s recommendations importance, and interest. An expedited consideration for reporting of harms. pathway, AJKD Express, is available for select For nonrandomized trials evaluating behavioral manuscripts redirected from high-profile and public health interventions, authors should publications. follow the TREND guidelines. An Original Investigation includes a structured Because adopting a shared set of key trial abstract of up to 300 words and is limited to 3,500 outcomes can help prevent selective reporting and words (excluding abstract, references, the article facilitate comparisons and pooling of results across information section, tables, and figure legends); trials, AJKD recommends authors determine most Original Investigations have no more than 50 whether there is a core outcome set relevant to their references and 8 figures/tables/boxes in total. The trial; if so, AJKD encourages authors to include such body of the manuscript is organized into Introduction, outcomes in their trial or briefly mention the rationale Methods, Results, and Discussion sections. for not adopting them. The COMET Initiative maintains Further information on subtypes of Original a searchable database of core outcome sets. Investigation, organized alphabetically by study Decision Analysis or Cost-Effectiveness Analysis design, is provided in the remainder of this section. An analysis that weighs choices in clinical care by Authors should follow the listed reporting guidelines modeling the projected consequences of different or consult materials at the Equator Network for strategies to identify the optimal choice and/or to guidance. Also, if reporting company-sponsored inform clinical decision making or public policy. research, authors should consult the Good Authors should follow the recommendations of the Publication Practice recommendations (GPP3). For Second Panel on Cost Effectiveness in Health and studies using laboratory testing of biomarkers, AJKD Medicine (JAMA 2016) or the CHEERS guidelines to endorses following the recommendations of the report economic evaluations of health interventions. Consortium of Laboratory Medicine Journal Editors. Diagnostic Test Study Case Series A study that compares the performance of 2 or A description of the clinical course of 11 or more more diagnostic tests or strategies. Authors should actual individuals with a condition of interest. A case follow the STARD guidelines. series typically focuses
Load more

Recommended publications
  • Open Access Availability of Scientific Publications
    Analytical Support for Bibliometrics Indicators Open access availability of scientific publications Analytical Support for Bibliometrics Indicators Open access availability of scientific publications* Final Report January 2018 By: Science-Metrix Inc. 1335 Mont-Royal E. ▪ Montréal ▪ Québec ▪ Canada ▪ H2J 1Y6 1.514.495.6505 ▪ 1.800.994.4761 [email protected] ▪ www.science-metrix.com *This work was funded by the National Science Foundation’s (NSF) National Center for Science and Engineering Statistics (NCSES). Any opinions, findings, conclusions or recommendations expressed in this report do not necessarily reflect the views of NCSES or the NSF. The analysis for this research was conducted by SRI International on behalf of NSF’s NCSES under contract number NSFDACS1063289. Analytical Support for Bibliometrics Indicators Open access availability of scientific publications Contents Contents .............................................................................................................................................................. i Tables ................................................................................................................................................................. ii Figures ................................................................................................................................................................ ii Abstract ............................................................................................................................................................
    [Show full text]
  • Obesity and Reproduction: a Committee Opinion
    Obesity and reproduction: a committee opinion Practice Committee of the American Society for Reproductive Medicine American Society for Reproductive Medicine, Birmingham, Alabama The purpose of this ASRM Practice Committee report is to provide clinicians with principles and strategies for the evaluation and treatment of couples with infertility associated with obesity. This revised document replaces the Practice Committee document titled, ‘‘Obesity and reproduction: an educational bulletin,’’ last published in 2008 (Fertil Steril 2008;90:S21–9). (Fertil SterilÒ 2015;104:1116–26. Ó2015 Use your smartphone by American Society for Reproductive Medicine.) to scan this QR code Earn online CME credit related to this document at www.asrm.org/elearn and connect to the discussion forum for Discuss: You can discuss this article with its authors and with other ASRM members at http:// this article now.* fertstertforum.com/asrmpraccom-obesity-reproduction/ * Download a free QR code scanner by searching for “QR scanner” in your smartphone’s app store or app marketplace. he prevalence of obesity as a exceed $200 billion (7). This populations have a genetically higher worldwide epidemic has underestimates the economic burden percent body fat than Caucasians, T increased dramatically over the of obesity, since maternal morbidity resulting in greater risks of developing past two decades. In the United States and adverse perinatal outcomes add diabetes and CVD at a lower BMI of alone, almost two thirds of women additional costs. The problem of obesity 23–25 kg/m2 (12). and three fourths of men are overweight is also exacerbated by only one third of Known associations with metabolic or obese, as are nearly 50% of women of obese patients receiving advice from disease and death from CVD include reproductive age and 17% of their health-care providers regarding weight BMI (J-shaped association), increased children ages 2–19 years (1–3).
    [Show full text]
  • Web of Science™ Core Collection Current Contents Connect®
    WEB OF SCIENCE™ CORE COLLECTION CURRENT CONTENTS CONNECT® XML USER GUIDE March, 2020 Table of Contents Overview 3 Support and Questions 4 Selection Criteria 5 XML Schemas 7 Schema Diagram 8 Source Record Identifiers 9 Document and Source Titles 11 Source Author Names 12 Full Names and Abbreviations 13 Chinese Author Names 13 Authors and Addresses 15 Research and Reprint Addresses 17 Organizations 18 Contributors 19 Cited References 21 Citations to Articles from Journal Supplements 22 Issue Information in the Volume Field 23 Cited Authors in References to Proceedings and Patents 23 © 2020 Clarivate Analytics 1 Counting Citations 24 Times Cited File 25 Delivery Schedule 26 Corrections and Gap Records 27 Deletions 28 Journal Lists and Journal Changes 29 Appendix 1 Subject Categories 30 Subject Catagories (Ascatype) 30 Web of Science™ Core Collection Subject Areas (Traditional Ascatype) 30 Research Areas (Extended Ascatype) 34 Current Contents Subject Codes 38 Current Contents Editions and Subjects 38 Appendix 2 Document Types 43 Document Types 43 Web of Science Core Collection Document Types 43 Current Contents Connect Document Types 44 Appendix 3 Abbreviations and Acronyms 46 Address Abbreviations 46 Country Abbreviations 51 Cited Patent Country Abbreviations 57 © 2020 Clarivate Analytics 2 Overview Your contract for raw data entitles you to get timely updates, which you may store and process according to the terms of your agreement. The associated XML schemas describe the record structure of the data and the individual elements that define
    [Show full text]
  • Assessment Report Triclosan Chemical Abstracts Service
    Assessment Report Triclosan Chemical Abstracts Service Registry Number 3380-34-5 Environment and Climate Change Canada Health Canada November 2016 Assessment Report: Triclosan 2016-11-26 En14-259/2016E-PDF 978-0-660-05976-1 Information contained in this publication or product may be reproduced, in part or in whole, and by any means, for personal or public non-commercial purposes, without charge or further permission, unless otherwise specified. You are asked to: Exercise due diligence in ensuring the accuracy of the materials reproduced; Indicate both the complete title of the materials reproduced, as well as the author organization; and Indicate that the reproduction is a copy of an official work that is published by the Government of Canada and that the reproduction has not been produced in affiliation with or with the endorsement of the Government of Canada. Commercial reproduction and distribution is prohibited except with written permission from the author. For more information, please contact Environment and Climate Change Canada’s Inquiry Centre at 1-800-668-6767 (in Canada only) or 819-997-2800 or email to [email protected]. © Her Majesty the Queen in Right of Canada, represented by the Minister of the Environment, 2016. Aussi disponible en français Assessment Report: Triclosan 2016-11-26 Synopsis An assessment of triclosan has been conducted under the Canadian Environmental Protection Act, 1999 (CEPA) to determine if it poses a risk to Canadians and their environment. Triclosan was also scheduled for re-evaluation under Health Canada’s Pest Management Regulatory Agency (PMRA) pesticide re-evaluation program pursuant to the Pest Control Products Act (PCPA).
    [Show full text]
  • Re: Revised Contract
    JOB TITLE: Managing and Business Development Editor, Reproductive BioMedicine Online (RBMO) COMPANY: Reproductive Healthcare Ltd LOCATION: Bourn Hall, High Street, Bourn, Cambridge CB23 2TN REPORTING TO: Chief Editor ACCOUNTABLE TO: Chairman KEY RELATIONS: Chief Editor, Chairman, Editors, Managing Secretary, Adjudicators, Publisher, Financial Adviser (An overview of engagement with authors) HOURS: Full time 37.5 hours Mondays to Fridays. ROLE: To work directly with the Chief Editor and Chairman on the efficient management and strategic development of the journal. KEY RESPONSIBILITIES: Regular analysis and reporting of key journal metrics to assess performance and inform management and development decisions. Progressing initiatives and developments (for example novel content strands) as outlined by the Chief Editor and Chairman Identification of potential new initiatives or subject areas, to strengthen the journal's position within the market sector, in discussion with the Chief Editor and Chairman. Progressing existing activities, including social media presence, compilation of a quarterly digest, press releases and media coverage as required, in close interaction with the Chief Editor and publisher. Page 1 of 3 Working with Editorial Office as necessary to help manage an efficient, rigorous and author-friendly peer-review process that maintains high professional and scientific standards. PROFILE: - Science Post doc/PhD, ideally with relevant subject background; - Excellent interactive, team-working skills, while also having the ability
    [Show full text]
  • UNDERSTANDING OPEN ACCESS When, Why, & How to Make Your Work Openly Accessible
    Lexi Rubow · Rachael Shen · Brianna Schofield Samuelson Law, Technology, and Public Policy Clinic UNDERSTANDING OPEN ACCESS When, Why, & How to Make Your Work Openly Accessible Authors Alliance · No. 2 © 2015 Authors Alliance, CC BY 4.0 Lexi Rubow Rachael Shen Brianna Schofield Samuelson Law, Technology, and Public Policy Clinic You are free to: Share: copy and redistribute the material in any medium or format. Adapt: remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms: Attribution: You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. No additional restrictions: You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. https://creativecommons.org/licenses/by/4.0 ISBN 0-6925-8724-1 No Legal Advice: While this guide provides information and strategies for authors who wish to understand and evaluate open access options, it does not apply this information to any individual author’s specific situation. This guide is not legal advice nor does using this guide create an attorney-client relationship. Please consult an attorney if you would like legal advice about your rights, obligations, or individual situation. Typeset by Jasmine Rae Friedrich in Titillium, Open Sans and Merriweather. UNDERSTANDING OPEN ACCESS When, Why, & How to Make Your Work Openly Accessible PREPARED FOR AUTHORS ALLIANCE BY: Lexi Rubow Rachael Shen Brianna Schofield Samuelson Law, Technology, and Public Policy Clinic ACKNOWLEDGEMENTS: Authors Alliance thanks Lexi Rubow, Rachael Shen, Brianna Schofield, and Berkeley Law’s Samuelson Law, Technology, and Public Policy Clinic for researching and authoring this guide.
    [Show full text]
  • The Scimago Journal & Country Rank and the JBRA
    JBRA Assisted Reproduction 2019;23(1):01 doi: 10.5935/1518-0557.20180082 Editorial The SCImago Journal & Country Rank and the JBRA Maria do Carmo Borges de Souza1,2, Paulo Franco Taitson3,4, João Batista Alcântara Oliveira5,6 1Editor-In-Chief- JBRA Assisted Reproduction 2Fertipraxis- Centro de Reprodução Humana- RJ, Brazil 3Assistant Editor - JBRA Assisted Reproduction 4Discipline of Human Reproduction - Pontifical Catholic University of Minas Gerais (MG), Brazil 5Associate Editor - JBRA Assisted Reproduction 6Center for Human Reproduction Prof. Franco Jr- Ribeirão Preto (SP), Brazil The SCImago Journal & Country Rank (SJR) is a pub- continents and dimensions of knowledge, a demand from licly available portal that includes journals and scientific an ever-growing field of publications. The reviewers’ group indicators from the information contained in the Scopus is extensive, comprising researchers from more than 60 (Elsevier®) database (Bar-Ilan, 2008; Guerrero-Bote & countries. The review of each submission is carried out in Moya-Anegón, 2012). These indicators can be used to as- a judicious and double blind fashion, and in the shortest sess and analyze scientific domains. The journals may be time. It is freely accessible to the community through this compared or analyzed separately. Country rankings can web link: www. jbra.com.br also be compared or analyzed separately. The journals can As Editors, we happily witness the journal progressing be grouped by field (27 main subject areas), subject cate- in every year and biennial assessments, showing a 62% in- gory (313 specific subject categories) or by country. Cita- crease in the number of papers cited in the last two years, tion data is drawn from more than 34,100 titles from more 97% in the number of references; ranking first among the than 5,000 international publishers, and performance met- specific journals in human reproduction in Latin America.
    [Show full text]
  • Practical Method to Reclassify Web of Science Articles Into Unique Subject Categories and Broad Disciplines
    RESEARCH ARTICLE Practical method to reclassify Web of Science articles into unique subject categories and broad disciplines Staša Milojević an open access journal Center for Complex Networks and Systems Research, Luddy School of Informatics, Computing, and Engineering, Indiana University, Bloomington Keywords: classification Downloaded from http://direct.mit.edu/qss/article-pdf/1/1/183/1760867/qss_a_00014.pdf by guest on 24 September 2021 ABSTRACT Citation: Milojević, S. (2020). Practical method to reclassify Web of Science articles into unique subject categories Classification of bibliographic items into subjects and disciplines in large databases is essential and broad disciplines. Quantitative for many quantitative science studies. The Web of Science classification of journals into Science Studies, 1(1), 183–206. https:// doi.org/10.1162/qss_a_00014 approximately 250 subject categories, which has served as a basis for many studies, is known to have some fundamental problems and several practical limitations that may DOI: https://doi.org/10.1162/qss_a_00014 affect the results from such studies. Here we present an easily reproducible method to perform reclassification of the Web of Science into existing subject categories and into 14 Received: 17 July 2019 Accepted: 03 December 2019 broad areas. Our reclassification is at the level of articles, so it preserves disciplinary differences that may exist among individual articles published in the same journal. Corresponding Author: Staša Milojević Reclassification also eliminates ambiguous (multiple) categories that are found for 50% of [email protected] items and assigns a discipline/field category to all articles that come from broad-coverage Handling Editor: journals such as Nature and Science. The correctness of the assigned subject categories Ludo Waltman is evaluated manually and is found to be ∼95%.
    [Show full text]
  • Epigenetics and Male Reproduction: the Consequences of Paternal
    Stuppia et al. Clinical Epigenetics (2015) 7:120 DOI 10.1186/s13148-015-0155-4 REVIEW Open Access Epigenetics and male reproduction: the consequences of paternal lifestyle on fertility, embryo development, and children lifetime health Liborio Stuppia1,3*, Marica Franzago1, Patrizia Ballerini2, Valentina Gatta1,3 and Ivana Antonucci1,3 Abstract The correlation between epigenetics and human reproduction represents a very interesting field of study, mainly due to the possible transgenerational effects related to epigenetic modifications of male and female gametes. In the present review, we focused our attention to the role played by epigenetics on male reproduction, evidencing at least four different levels at which sperm epigenetic modifications could affect reproduction: (1) spermatogenesis failure; (2) embryo development; (3) outcome of assisted reproduction technique (ART) protocols, mainly as concerning genomic imprinting; and (4) long-term effects during the offspring lifetime. The environmental agents responsible for epigenetic modifications are also examined, suggesting that the control of paternal lifestyle prior to conception could represent in the next future a novel hot topic in the management of human reproduction. Keywords: Male infertility, Gametogenesis, Epigenetics, DNA methylation, Transgenerational effect Background the large number of tools available for the identification of the pathogenesis of male infertility, in many cases, no You shall not bow down to them or worship them; specific cause is detected and no personalized thera- for I, the Lord your God, am a jealous God, peutic protocol can be established. A large number of punishing the children for the sin of the parents studies have investigated in the last decades the presence to the third and fourth generation of those who hate me of genetic alterations responsible for the failure of spermatogenesis, which are nevertheless identified only (Esodus, 20.5) in 15–30 % of infertile males, even when stringent selec- tion criteria are used [3, 4].
    [Show full text]
  • REPRODUCTION, FERTILITY and DEVELOPMENT Publish.Csiro.Au/Rd
    REPRODUCTION, FERTILITY AND DEVELOPMENT publish.csiro.au/rd SCOPE 953–1026 32(11) 2020 PAGES VOL. Reproduction, Fertility Reproduction, Fertility Reproduction, Fertility and Developmentand Development is an international journal for the publication of original and significant and Development contributions to the field of reproductiveContents Volume 32 Issue 11 2020 biology in vertebrate Type I interferon receptors and interferon-τ-stimulated genes in peripheral blood mononuclear cells and polymorphonuclear leucocytes during early pregnancy in beef heifers G. D. Melo, L. M. F. Pinto, C. C. Rocha, I. G. Motta, L. A. Silva, J. C. da Silveira, A. M. Gonella-Diaza, M. Binelli and G. Pugliesi 953 Characteristics of lipid droplets and the expression of proteins involved in lipolysis in the murine cervix during animals, including humans, livestockmid-pregnancy and wildlife. L. Tao, H. Zhang, H.Wang, L. Li, L. Huang, F. Su, X. Yuan, M. Luo and L. Ge 967 Gene and protein expression of connexins 37 and 43 in cumulus–oocytes complexes throughout the canine oestrous cycle M. De los Reyes, J. Palomino, C. Gallegos, R. Espinoza, P. Dettleff, O. A. Peralta,V. H. Parraguez and G. Ramirez 976 AND DEVELOPMENT FERTILITY REPRODUCTION, Insulin-like growth factors 1 and 2 are associated with testicular germ cell proliferation and apoptosis during fish reproduction D. P. Moreira, R. M. C. Melo, A. A. Weber and E. Rizzo 988 Subject areas include, but are Effectsnot of bone morphogeneticlimited protein 15 (BMP15 ) knockdownto: on physiology,porcine testis morphology and spermatogenesis T. Tang, Q. Lin,Y. Qin, X. Liang, Y. Guo, P. Cong, X. Liu,Y.
    [Show full text]
  • ANIMAL REPRODUCTION SCIENCE an International Journal
    ANIMAL REPRODUCTION SCIENCE An International Journal AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Audience p.1 • Impact Factor p.2 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.4 ISSN: 0378-4320 DESCRIPTION . Animal Reproduction Science publishes results from studies relating to reproduction and fertility in animals. This includes both fundamental research and applied studies, including management practices that increase our understanding of the biology and manipulation of reproduction. Manuscripts should go into depth in the mechanisms involved in the research reported, rather than give a mere description of findings. Results and conclusions should contribute to improving the management of an animal species or population, with regard to its fertility or reproductive efficiency. Results and conclusions should contribute to improving the management of an animal species or population, with regard to its fertility or reproductive efficiency. The focus is on animals that are useful to humans including food- and fibre-producing; companion/recreational; captive; and endangered species including zoo animals, but excluding laboratory animals unless the results of the study provide new information that impacts the basic understanding of the biology or manipulation of reproduction. The journal's scope includes the study of reproductive physiology and endocrinology, reproductive cycles, natural and artificial control of reproduction, preservation and use of gametes and embryos, pregnancy and parturition, infertility and sterility, diagnostic and therapeutic techniques. The Editorial Board of Animal Reproduction Science has decided not to publish papers in which there is an exclusive examination of the in vitro development of oocytes and embryos; however, there will be consideration of papers that include in vitro studies where the source of the oocytes and/or development of the embryos beyond the blastocyst stage is part of the experimental design.
    [Show full text]
  • Introducing Reproduction and Fertility
    ID: XX-XXXX; -20-0001 1 1 N Spears and A W Horne Introducing Reproduction and 1:1 C1–C2 Fertility COMMENTARY Introducing Reproduction and Fertility Norah Spears1 and Andrew W Horne2 1University of Edinburgh – Biomedical Sciences, Edinburgh, UK 2University of Edinburgh – MRC Centre for Reproductive Health, Edinburgh, UK Correspondence should be addressed to N Spears: [email protected] Reproduction and Fertility (2020) 1 C1–C2 When the Journal of Reproduction and Fertility (now known work prior to completion of a more comprehensive as Reproduction) was launched 60 years ago in 1960, it study or to publish small but scientifically robust addressed the need for a formal publication to represent studies where that avenue of research has not been the members of what was then the Society for the Study of further pursued. Fertility (now the Society for Reproduction and Fertility; 3. In alignment with the greater visibility proffered by SRF). Through the years, the journal’s successive editorial publishing articles open access, authors will be asked boards have molded it into one that has the reputation of to provide a short Lay Summary of their article, being a leading title in reproductive biology. a condensed summary intended for the public or In recent years, the SRF identified the need for a new those working outside of the immediate field. These publication outlet for its members and authors, one which summaries will offer authors the opportunity to share is fully open access and devoted to the entire breadth of their perspective on the wider impact of their work.
    [Show full text]